UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET ...

Shares of ProPhase Labs, Inc. (PRPH) have been struggling lately and have lost 21% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is ProPhase Labs, Inc. (PRPH) one of those stocks right now? Let ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. ProPhase Labs, Inc. (PRPH) is a stock that can certainly grab the attention of many ...

ProPhase Labs thrived in the Covid era and then wisely used the gains to invest in new testing capabilities including whole genome sequencing and a new esophageal cancer test. The capabilities will ...

ProPhase Labs, Inc. (PRPH) shares ended the last trading session 8.5% higher at $8.42. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

There are no upcoming dividends for ProPhase Labs.The last dividend paid last dividend payout June 3, 2022 and was $0.30. ProPhase Labs has no upcoming dividends reported. The last reported dividend ...

ProPhase Labs, Inc. PRPH shares rallied 9.1% in the last trading session to close at $14.15. This move can be attributable to notable volume with a higher number of shares being traded than in a ...